Vaccines on demand, part II: future reality-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vaccines on demand, part II: future reality

Published:2022-11-23 Issue:2 Volume:18 Page:119-127
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Geall Andrew J.¹,Kis Zoltan²³,Ulmer Jeffrey B.⁴⁵

Affiliation:

1. Replicate Biosciences, San Diego, CA, USA

2. Department of Chemical and Biological Engineering, The University of Sheffield, Sheffield, UK

3. Department of Chemical Engineering, Imperial College London, London, UK

4. Immorna Biotherapeutics, Morrisville, North Carolina

5. TechImmune LLC, Newport Beach, CA, USA

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2022.2147501

Reference51 articles.

1. An Update on Self-Amplifying mRNA Vaccine Development

2. How COVID unlocked the power of RNA vaccines

3. ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity

4. Induction of virus-specific cytotoxic T lymphocytesin vivo by liposome-entrapped mRNA

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency;Nature Biotechnology;2024-07-08

2. Self-amplifying RNAs generated with the modified nucleotides 5-methylcytidine and 5-methyluridine mediate strong expression and immunogenicity in vivo;NAR Molecular Medicine;2024-04-01

3. New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement;Vaccines;2024-02-24

4. Introduction to RNA Vaccines Post COVID-19;Methods in Molecular Biology;2024

5. Complete substitution with modified nucleotides suppresses the early interferon response and increases the potency of self-amplifying RNA;2023-09-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3